These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

842 related items for PubMed ID: 26809245

  • 1. Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.
    Magro-Checa C, Zirkzee EJ, Huizinga TW, Steup-Beekman GM.
    Drugs; 2016 Mar; 76(4):459-83. PubMed ID: 26809245
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Value of multidisciplinary reassessment in attribution of neuropsychiatric events to systemic lupus erythematosus: prospective data from the Leiden NPSLE cohort.
    Magro-Checa C, Zirkzee EJ, Beaart-van de Voorde LJJ, Middelkoop HA, van der Wee NJ, Huisman MV, Eikenboom J, Kruyt ND, van Buchem MA, Huizinga TWJ, Steup-Beekman GM.
    Rheumatology (Oxford); 2017 Oct 01; 56(10):1676-1683. PubMed ID: 28339952
    [Abstract] [Full Text] [Related]

  • 4. Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach.
    Sanna G, Bertolaccini ML, Khamashta MA.
    Curr Pharm Des; 2008 Oct 01; 14(13):1261-9. PubMed ID: 18537650
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review.
    Constantin A, Năstase D, Tulbă D, Bălănescu P, Băicuș C.
    Lupus; 2020 Oct 01; 29(12):1509-1519. PubMed ID: 32757735
    [Abstract] [Full Text] [Related]

  • 6. Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review.
    Papachristos DA, Oon S, Hanly JG, Nikpour M.
    Semin Arthritis Rheum; 2021 Feb 01; 51(1):49-71. PubMed ID: 33360230
    [Abstract] [Full Text] [Related]

  • 7. Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management.
    Tayer-Shifman OE, Bingham KS, Touma Z.
    Drugs Aging; 2022 Feb 01; 39(2):129-142. PubMed ID: 34913146
    [Abstract] [Full Text] [Related]

  • 8. [Neuropsychiatric Systemic Lupus Erythematosus].
    Tanaka Y.
    Brain Nerve; 2016 Sep 01; 68(9):1035-1048. PubMed ID: 27667489
    [Abstract] [Full Text] [Related]

  • 9. Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE.
    Shimizu Y, Yasuda S, Kako Y, Nakagawa S, Kanda M, Hisada R, Ohmura K, Shimamura S, Shida H, Fujieda Y, Kato M, Oku K, Bohgaki T, Horita T, Kusumi I, Atsumi T.
    Autoimmun Rev; 2016 Aug 01; 15(8):786-94. PubMed ID: 27016478
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic management of neuropsychiatric lupus.
    Kivity S, Baker B, Arango MT, Chapman J, Shoenfeld Y.
    Expert Rev Clin Pharmacol; 2016 Aug 01; 9(1):103-8. PubMed ID: 26559084
    [Abstract] [Full Text] [Related]

  • 11. Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges.
    Sarwar S, Mohamed AS, Rogers S, Sarmast ST, Kataria S, Mohamed KH, Khalid MZ, Saeeduddin MO, Shiza ST, Ahmad S, Awais A, Singh R.
    Cureus; 2021 Sep 01; 13(9):e17969. PubMed ID: 34667659
    [Abstract] [Full Text] [Related]

  • 12. Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus.
    Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG.
    Am J Med; 1995 Jan 01; 98(1):32-41. PubMed ID: 7825616
    [Abstract] [Full Text] [Related]

  • 13. A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.
    Ercan E, Ingo C, Tritanon O, Magro-Checa C, Smith A, Smith S, Huizinga T, van Buchem MA, Ronen I.
    Neuroimage Clin; 2015 Jan 01; 8():337-44. PubMed ID: 26106559
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychiatric systemic lupus erythematosus.
    Popescu A, Kao AH.
    Curr Neuropharmacol; 2011 Sep 01; 9(3):449-57. PubMed ID: 22379459
    [Abstract] [Full Text] [Related]

  • 15. [Systemic lupus erythematosus associated macrophage activation syndrome with neuropsychiatric symptoms: A report of 2 cases].
    Luo ZJ, Wu JJ, Song Y, Mei CL, DU R.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec 18; 55(6):1111-1117. PubMed ID: 38101797
    [Abstract] [Full Text] [Related]

  • 16. Neuropsychiatric Systemic Lupus Erythematosus (NPSLE): A Case Report and an Overview of the Diagnosis, Treatment Modalities, and Prognosis.
    Syed A, Shaik S, Afshan R, Karam A, Hafeez W, Almansour S.
    Cureus; 2024 Jul 18; 16(7):e65593. PubMed ID: 39192937
    [Abstract] [Full Text] [Related]

  • 17. Neuropsychiatric Systemic Lupus Erythematosus: A Remaining Challenge.
    Mrak D, Bonelli M, Radner H.
    Curr Pharm Des; 2022 Jul 18; 28(11):881-891. PubMed ID: 35549864
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G, Danza A, Khamashta M.
    Med Clin (Barc); 2013 Dec 21; 141(12):533-42. PubMed ID: 23622892
    [Abstract] [Full Text] [Related]

  • 19. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T, Bogucki A, Krupińska-Kun M, Maurer M, Woźniacka A.
    Lupus; 2015 Dec 21; 24(14):1492-7. PubMed ID: 26124236
    [Abstract] [Full Text] [Related]

  • 20. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause.
    Steup-Beekman GM, Zirkzee EJ, Cohen D, Gahrmann BM, Emmer BJ, Steens SC, Bollen EL, van Buchem MA, Huizinga TW.
    Ann Rheum Dis; 2013 Apr 21; 72 Suppl 2():ii76-9. PubMed ID: 23253914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.